CRISPR Therapeutics AG (CRSP)
$50.10-2.81%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV28.4%–102.0%
- Market cap
- $4.8B
- Beta
- 1.76
- P/E (TTM)
- -10.53
- IV-%ile
- 95
- IV ATM
- 80.5%
- Short % float
- 19.45%
- Days to cover
- 9.6
- SI change
- -2.0%
- 1W
- -7.22%
- 1M
- -5.40%
- vs SPY 1W
- -7.08%
- vs SPY 1M
- -7.91%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on CRSP?
- LOPJLB’s latest quantitative signal on CRISPR Therapeutics AG (CRSP) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CRSP in?
- CRISPR Therapeutics AG (CRSP) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does CRISPR Therapeutics AG (CRSP) do?
- CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's genetic code. Its extensive pipeline includes thera…